Abstract Details

Title Question of the Day: A Learning Success

Topic Education, Research, and Methodology

Presentation(s) S10 - Utilizing Varied Modalities to Impact Learning and Make Curricular Changes (3:30 PM-3:42 PM)

Poster/Presentation
Number 001

Background QOD, launched in 2020, provides daily board exam–style multiple-choice questions in two tracks: one for practicing neurologists and one for medical students. Questions for neurologists follow a yearly curriculum based on the American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification (MOC) content outline. Topics include a wide variety of neurology subspecialties. Each question is accompanied by a detailed rationale and current references, many of which are hyperlinked to peer-reviewed resources. Users can earn up to 29 self-assessment continuing medical education (SA-CME) per year, which is 2 SA-CME per 25 QOD questions. The ABPN has approved QOD as part of a comprehensive lifelong learning program.

Objective

To demonstrate the successful implementation of the American Academy of Neurology (AAN) Question of the Day (QOD) mobile application and its value to AAN members.

Design/Methods Data collected from QOD since April 2021 include activity by AAN member type, total active daily users, number of CME earned, and program evaluation data.

Results Total users per year were 5.6K, 9.5K, and 11K for 2020, 2021, and 2022, respectively, with practicing neurologists (25%) and junior (59%) AAN members the most engaged, and with participation from 123 countries. Average daily users increased from 1.4K in 2021 to 1.5K in 2022, with weekly (2.7K) and monthly (4.3K) usage comparable in 2021 and 2022. In total, 8.7K hours of SA-CME have been claimed in 2022 compared with 5.8K in 2021. Satisfaction has remained high since launch and is currently 99%. Users report that the questions are useful, fair, balanced, and of high quality.

Conclusions Since its introduction in 2020, QOD has become a very popular, effective continuing education program for AAN members. There has been substantial growth of new users each year while maintaining a strong contingency of daily users.

Authors/Disclosures
Jerome J. Graber, MD, MPH, FAAN (University of Washington) PRESENTER	Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurogical Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Eric J. Seachrist, MD (West Virginia University)	Dr. Seachrist has stock in Medtronic. Dr. Seachrist has stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
Lynne Shindoll, MA (American Academy of Neurology)	Ms. Shindoll has nothing to disclose.
Gauri V. Pawar, MD, FAAN (West Virginia University)	Dr. Pawar has nothing to disclose.
Zachary N. London, MD, FAAN (University of Michigan)	Dr. London has nothing to disclose.
Humaira Khan, MD (CAVHS)	Dr. Khan has nothing to disclose.
Jeff Kraakevik, MD, FAAN	The institution of Dr. Kraakevik has received research support from Parkinson Foundation.
Felicia Gliksman, DO, FAAN (Hackensack University Medical Center)	Dr. Gliksman has nothing to disclose.